Issue 11/2003
Content (12 Articles)
The neuroprotective effects of Cerebrolysin™ in a transgenic model of Alzheimer’s disease are associated with improved behavioral performance
E. Rockenstein, A. Adame, M. Mante, H. Moessler, M. Windisch, E. Masliah
Expression of cannabinoid CB1 receptor mRNA in basal ganglia of normal and parkinsonian human brain
M. J. Hurley, D. C. Mash, P. Jenner
A new formulation of selegiline: improved bioavailability and selectivity for MAO-B inhibition
A. Clarke, F. Brewer, E. S. Johnson, N. Mallard, F. Hartig, S. Taylor, T. H. Corn
The interaction of tetrahydroisoquinoline derivatives with antinociceptive action of morphine and oxotremorine in mice
J. Vetulani, F. Pavone, B. Przewłocka, V. Borghi, I. Nalepa
Spatial correlations between the vacuolation, prion protein deposition and surviving neurons in variant Creutzfeldt-Jakob Disease (vCJD)
R. A. Armstrong, P. L. Lantos, J. W. Ironside, N. J. Cairns
Activation of basal ganglia loops in idiopathic Parkinson’s disease: a PET study
A. Thiel, R. Hilker, J. Kessler, B. Habedank, K. Herholz, W.-D. Heiss
A new low-dose formulation of selegiline: clinical efficacy, patient preference and selectivity for MAO-B inhibition
A. Clarke, E. S. Johnson, N. Mallard, T. H. Corn, A. Johnston, M. Boyce, S. Warrington, D. G. MacMahon
Acute effects of estrogen upon methamphetamine induced neurotoxicity of the nigrostriatal dopaminergic system
T. M. Gajjar, L. I. Anderson, D. E. Dluzen
Short Communication
Mutation analysis of the zinc transporter gene SLC30A4 reveals no association with periodic catatonia on chromosome 15q15
S. Küry, C. Rubie, J. P. Moisan, G. Stöber